Camp4 Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$4.37

-0.07 (-1.58%)

As of Jun 30, 10:25 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +174.8% upside

Low Target $8.14

Average Target $12.01

High Target $13.09

Current Price $4.37

Current
$4.37

Target
$12.01

$8.14 $12.01 avg $13.09

Scenario Analysis

Bear Case

$8.14

86.3%

Low target

Base Case

$12.01

+174.8%

Avg target

Bull Case

$13.09

+199.5%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$7.75

-43.6% from high

52-Week Low

$1.32

+231.1% from low

Target vs 52W High

$12.01

+55.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%